SecBot SecBot

MET

METLIFE INC
NYSE· Life Insurance· Inc. DE· CIK 0001099219 Traditional Finance
$101.45 −1.20 (−1.17%)
Nov 16 4:00 PM ET · prev $102.65
Market cap
$64.1B
Large cap
Consensus
Buy
75% Buy or better · 24 analysts
Median target
$111.50
+10% · range $84.00–131.00
1 year
+34.3%
from $75.53 · Nov 17
30 days
+1.9%
from $99.58
52-week range
$67.70–103.57
−2% from high · low Mar 27
Avg volume 20D
3.17M
shares / day
Short interest
10.75M
≈1.7% of shares · −0.1%
Days to cover
3.4
at average volume
Insider net
−$21.0M
0 buyers · 2 sellers · since Jun 1
New fund stakes
3
Q2 2026 13F · 0 exits
Filing reports
17
analyzed by SecBot
SecBot read BULLISH 10 reports · 90 days
Balance 0 bearish · 1 bullish · 9 neutral oldest → newest, height = score
Avg score ·High conf. 8/10

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    2 insiders sold $21.0M.

  • InstitutionsMIXED

    Q2 2026: 49 added (3 new), 33 trimmed or exited. Largest new: Freestone Grove Partners $100.2M, Alyeska Investment Group, $24.8M.

  • AnalystsBULLISH

    18 of 24 rate it Buy or better. Median target $111.50 (+10%).

  • Short sellersSTEADY

    Short interest −0.1% to 10.75M shares. 3.4 days to cover, ≈1.7% of shares.

  • TrendUPTREND

    3% above its 50-day average.

Who's buying

13F· Q2 2026
3
new positions
0
exits
$136.1M
in new stakes
FundMoveSharesValue
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPADD5,808,715$491.5M
AmundiADD3,627,717$306.9M
AMERIPRISE FINANCIAL INCTRIM3,474,206$294.0M
HSBC HOLDINGS PLCADD2,568,764$217.2M
UBS Group AGTRIM2,440,347$206.5M
AMERICAN CENTURY COMPANIES INCADD2,162,758$183.0M
PANAGORA ASSET MANAGEMENT INCDOUBLED1,270,174$107.5M
Man Group plcTRIM1,223,668$103.5M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

24 analysts
Buy 75% rate it Buy or better
Strong Buy5Buy13Hold6Sell0Strong Sell0
12-month targets · 16 analysts

Price is inside the target range. Median implies +10%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Nov 12, 2026Wells Fargo
MAINTAIN
MAINTAINOverweight
Nov 12, 2026Mizuho
MAINTAIN
MAINTAINOutperform
Nov 9, 2026Piper Sandler
MAINTAIN
MAINTAINOverweight
Oct 21, 2026TD Cowen
MAINTAIN
MAINTAINBuy
Oct 15, 2026JP Morgan
MAINTAIN
MAINTAINOverweight
Oct 12, 2026Wells Fargo
MAINTAIN
MAINTAINOverweight

Insider ledger

Form 4
$0
bought · 0 insiders
$21.0M
sold · 2 insiders
DateInsiderTypeValue
Nov 10, 2026
Khalaf Michel
President & CEO
Nov 10, 2026
EXERCISE$1.4M
Nov 10, 2026
Khalaf Michel
President & CEO
Nov 10, 2026
EXERCISE$4.1M
Nov 10, 2026
Khalaf Michel
President & CEO
Nov 10, 2026
SELL$19.3M
Nov 10, 2026
Khalaf Michel
President & CEO
Nov 10, 2026
EXERCISE$1.6M
Nov 10, 2026
Khalaf Michel
President & CEO
Nov 10, 2026
EXERCISE$4.5M
Oct 1, 2026
Hay Laura J
Director
Oct 1, 2026
AWARD$51.3K
Oct 1, 2026
Glaser Daniel S
Director
Oct 1, 2026
AWARD$51.3K
Oct 1, 2026
Johnson Jeh C.
Director
Oct 1, 2026
AWARD$51.3K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q$2.58$2.39–$2.78-0.2%$20.5B
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Washington

Corporate Lobbying

3 lobbying filings and 5 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 30, 2026
10,747,491
shares short
-0.1%
vs prior settlement
3.4
days to cover
≈1.7%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 12, 2026 SEC
Dodge & Cox filed an amended Schedule 13G disclosing a 5.3% passive stake in MetLife as of September 30, 2026, up from…
SC 13G/A · Impact 2/10
Nov 10, 2026 SEC
MetLife CEO Michel Khalaf filed a Form 144 notice of intent to sell 187,425 shares of common stock, valued at…
144 · Impact 3/10
Nov 9, 2026 SEC
MetLife amended and restated its existing credit agreement, increasing the aggregate lender commitments to $4.0…
8-K · Impact 3/10
Nov 10, 2026 Insider
Khalaf Michel acquired via exercise 28,817 shares
President & CEO @ $46.85 ($1.4M)
Nov 10, 2026 Insider
Khalaf Michel acquired via exercise 90,726 shares
President & CEO @ $44.65 ($4.1M)
Nov 10, 2026 Insider
Khalaf Michel sold 187,425 shares
President & CEO @ $102.97 ($19.3M)
Nov 4, 2026 Earnings result
MET Q3 2026 Earnings: EPS $2.85 (+1.7% vs est)
Jun 30, 2026 Inst.
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP · ADD
5,808,715 shares ($491.5M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Nov 4, 2026
Earnings result
MET Q3 2026 Earnings: EPS $2.85 (+1.7% vs est)
Aug 5, 2026
Earnings date
MET Q2 2026 Earnings After Market Close, 2026-08-05
May 13, 2026
Short interest
FTD: MET, 10,243 shares ($0.8M) failed to deliver
Settlement: 20260513, Price: $78.64, FTD Value: $805,509.52, METLIFE, INC
May 12, 2026
Short interest
FTD: MET, 10,835 shares ($0.8M) failed to deliver
Settlement: 20260512, Price: $77.98, FTD Value: $844,913.3, METLIFE, INC
May 11, 2026
Short interest
FTD: MET, 31,019 shares ($2.4M) failed to deliver
Settlement: 20260511, Price: $78.08, FTD Value: $2,421,963.52, METLIFE, INC

SecBot reports

17 filings · 1 bullish · 1 bearish · 15 neutral
All MET filing & press-release reports (17)